Izun Pharmaceuticals has established a new project team to expand into a significant and inadequately addressed therapeutic area in Women’s Health care, Atrophic Vaginitis (AV). This condition develops in women experiencing a drop in estrogen levels. AV occurs in 50% of post- menopausal women and develops in most women undergoing treatment for breast cancer.
Posts Tagged ‘Atrophic Vaginitis’
Read More January 6, 2013